ARVN

Arvinas, Inc.

NASDAQ

Add Alert

ARVN

Arvinas, Inc.

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Monksdream PremiumMember

02/17/24 2:48 PM

Post #29

ARVN new 52=week high

Monksdream PremiumMember

02/10/24 1:55 PM

Post #28

ARVN new 52 week high

Monksdream PremiumMember

02/06/24 2:49 PM

Post #27

ARVN new 52 week high

Monksdream PremiumMember

12/25/23 11:33 AM

Post #26

ARVN new 52 week high

crudeoil24 PremiumMember

12/14/20 9:19 AM

Post #25

ARVN up 138% > "Based on data to date, we believe ARV-471 is the most promising ER-targeting therapy in the clinic, showing early signs of efficacy, a favorable tolerability profile, and better ER degradation than that previously reported for fulvestrant, the current standard of care,” said Ron Peck, Ph.D., Chief Medical Officer at Arvinas. “It is exciting to see that ARV-110 continues to be active and well tolerated in what we believe is the most heavily pretreated patient population that has ever been studied with an AR-directed therapy. Our recently initiated ARDENT Phase 2 cohort expansion is specifically designed to investigate the potential of a precision medicine approach in molecularly defined, late-line patients with few available treatment options, while also fully characterizing the safety and activity of ARV-110 in earlier line patients irrespective of molecular profile, setting ARV-110 on a potential two-pronged registrational path.”

biocqr

12/17/19 10:29 AM

Post #24

Advantages of PROTACs vs. inhibition...

message_id=152832655

G-lupo

11/29/19 12:15 AM

Post #23

Re: #22: @boo boo - Starting to see a chink in the armor!

Idk about that, I thought it had some resistance and kept going through, I think at this next convention their going to release some positive news. I’m so holy I didn’t sell at $30 which was ceiling I thought. Do have in a $35 limit sell thought if drops. Rebuy anything under $25

boo boo

11/26/19 5:04 PM

Post #22

Starting to see a chink in the armor!

G-lupo

11/15/19 5:01 PM

Post #21

Possibly wall at 30.50

G-lupo

11/14/19 1:08 PM

Post #20

Re: #18: @boo boo - Benzinga 11/14/2019:

I feel people are going to start taking profits before $35 price target and give it a dip back.
Question is what is that dip price

boo boo

11/14/19 10:19 AM

Post #19

The offering:

8-k

boo boo

11/14/19 10:05 AM

Post #18

Benzinga 11/14/2019:

With a rating of Buy, Roth Capital initiated coverage on Arvinas Inc (NASDAQ:ARVN). The price target is set at $35.00 for Arvinas. In the third quarter, Arvinas showed an EPS of $0.21, compared to ($62.38) from the year-ago quarter. The current market cap for Arvinas is at $696.1 million. The stock has a 52-week-high of $28.96 and a 52-week-low of $10.19. Arvinas's stock last closed at $28.38 per share.

I might post a chart in about a week, well after everything plays out!

boo boo

11/13/19 12:53 PM

Post #17

Re: #16: @G-lupo - Thanks, I’m in it, thought $28 would be

It doesn't have to be a PR:

#8

G-lupo

11/13/19 12:47 PM

Post #16

Re: #15: @boo boo - https://polsonnews.com/arvinas-inc-nasdaqarvn-receives-34-33-average-pt-fro

Thanks, I’m in it, thought $28 would be resistant and broke through looks may break $30

boo boo

11/13/19 11:11 AM

Post #15

https://polsonnews.com/arvinas-inc-nasdaqarvn-receives-34-33-average-pt-from-brokerages/

G-lupo

11/13/19 11:03 AM

Post #14

Re: #13: @boo boo - If I were in this one (I'm not),

When did they Do a price target announcement? I didn’t see that.

boo boo

11/13/19 10:14 AM

Post #13

If I were in this one (I'm not), I'd be finding the exit on the price target announcement.

G-lupo

11/05/19 5:05 PM

Post #12

Arvn looking good, defintely see $26-27

G-lupo

10/29/19 11:53 AM

Post #11

Re: #10: @boo boo - Not me. I look for the trade

What you mean IBD?

boo boo

10/29/19 11:12 AM

Post #10

Re: #9: @G-lupo - I agree I own a decent amount, purchased

Not me. I look for the trade setup. Learned of this one from IBD and have been following...waiting. Missed the opportunity by 1 day. Would've, Should've, Could've...

G-lupo

10/29/19 11:05 AM

Post #9

Re: #8: @boo boo - Missing a trade and people who post a

I agree I own a decent amount, purchased from $22 down to $15.50. In for the long haul

boo boo

10/29/19 10:06 AM

Post #8

Re: #7: @G-lupo - What are you talking about ? Saw the

Missing a trade and people who post a purchase at a specific price well after that price has passed.

The bottom of the prior range (July thru September) is resistance as far as I'm concerned and you have a couple important SMA's around there. And I agree that a break of $27 could lead to a higher price. Wouldn't be as confident if a press release occurred at the same time, but then again depends on what is said.

G-lupo

10/28/19 9:30 PM

Post #7

Re: #6: @boo boo - Screwed this one up. More and better

What are you talking about ?

Saw the rebound at $16, going to get probably Around $25-26, if gets there look for resistance to drop back. Like this stock and with more news if breaks $27 could see $60

boo boo

10/25/19 4:07 PM

Post #6

Screwed this one up. More and better content on biotech values board. And no, I don't think this individual bought 'yesterday' and posted about it the day after. That's crap and not credible...POSER!